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Introduction 
The route for the delivery of drugs that is still the most popular with medical staff and 
patients alike is through the mouth and down the alimentary tract: the oral route. The 
major site for drug absorption by this route is the small intestine which offers ≈ 100 m2 of 
surface epithelia across which transfer can at least in principle take place. If the drug is 
poorly soluble, or is in the form of a controlled release dosage form, significant 
absorption of the drug may also occur in the large intestine (Davis, 1989). However, the 
clearance time through the whole alimentary tract is generally too short (4–12 h), 
rendering oral drug administration a very inefficient process, with much of the drug 
unabsorbed. More recently interest has focused on drug absorption through nasal 
epithelia, where again clearance problems are an issue. Consideration is also given to 
other delivery routes (e.g. vaginal and ocular). Other important issues are the degradation 
of peptide-based drugs in the gastrointestinal tract and low trans-mucosal permeability. 
Macromolecular based carrier and mucoadhesive systems have been considered for 
several years and two polysaccharide based systems have emerged as particularly 
promising: chitosans (cationic) and low-methoxy pectins (anionic).  
 
Chitosan 
Chemical Structure 
Chitosan is the generic name for a family of strongly polycationic derivatives of poly-N-
acetyl-D-glucosamine (chitin) it is found in the exoskeletons of crustaceans such as crabs 
and shrimps, but can also be found in the cell wall of fungi and bacteria (Tombs and 
Harding, 1998; Rinaudo, 2006; Yen and Mau, 2007).  In chitosan (Figure 1) the N-acetyl 
group is replaced either fully or partially by NH2 therefore the degree of acetylation can 
vary from DA = 0 (fully deacteylated) to DA = 1 (fully acetylated i.e. chitin).   Acetylated 
monomers (GlcNAc; A-unit) and deacteylated monomers (GlcN; D-unit) have been 
shown to be distributed randomly or block wise (Vårum, et al., 1991a, 1991b).  
 
Chitosan is biodegradable, non-toxic, non-immunogenic and biocompatible (Terbojevich 
and Muzzarelli, 2000) and as the only naturally occurring polycationic polymer chitosan 
and its derivatives have received a great deal of attention from, for example, the food, 
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cosmetic and pharmaceutical industries.  Important applications include water and waste 
treatment, antitumor, antibacterial and anticoagulant properties (Illum, 1998; Rinaudo, 
2006; Muzzarelli, 2009).   
 
Physical properties 
Chitosan is a semi-crystalline polymer (solid), which exhibits a degree of polymorphism 
(Ogawa and Yui, 1994). In an aqueous acidic environment, chitosan is promptly 
solubilised, as a result of the removal of the acetyl moieties present in the amine 
functional groups.  This solubility is limited, however, in inorganic acids compared to its 
solubility in organic acids. Solubilisation occurs as a consequence of the protonation of -
NH2 functional groups on the C-2 position of D-glucosamine residues.  Chitosan is a 
weak base with pKa values ranging from 6.2 to 7 and at physiological pH 7.4 or higher, 
low solubility is shown (Park, et al., 1983). However, chitosan’s solution properties are 
dependent on the distribution of its acetyl groups and the molecular weight of the 
polymer (Kubota and Eguchi, 1997). The solubility of chitosan in water increases with 
increasing DA (Vårum et al., 1994). With the addition of electrolytes to the solution, the 
aqueous solubility of chitosan is affected and salting out of chitosan can be seen as in the 
case of excessive hydrochloric acid use, and the resulting formation of chitosan 
chlorhydrate (Rinaudo, 2006).  Salting out can also be used to recover chitosan from 
solution and salting out efficiency of anions follows the Hofmeister series SO42- > H2PO4 
≈ HPO42- > NO3- (LeHoux and Depuis, 2007). With an extended chitosan conformation, 
due to the repelling effect of each positively charged deacetylated unit, the addition of 
electrolytes reduces the inter-chain repulsion and induces a more random coil-like 
conformation in the molecule (Terbojevich and Muzzarelli, 2000). 
 
Molecular weight, pH, ionic strength, and temperature are all factors which affect the 
viscosity of chitosan. Hydrodynamic studies based on intrinsic viscosity ([η]), 
sedimentation coefficient (s020,w), radius of gyration (rg) and weight average molecular 
weight (Mw) have focussed on qualitative/ semi-quantitative methods of estimating the 
conformation based around “power law” Mark-Houwink-Kuhn-Sakurada relations 
(Tombs and Harding, 1998) which link intrinsic viscosity, sedimentation coefficient and 
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radius of gyration with molar mass [η] ∝ Ma, s020,w ∝ Mb and rg ∝ Mc, where a, b and c 
have defined values for specific conformation types (Table 1). The translational frictional 
ratio, f/fo (Tanford, 1961), sedimentation conformation zoning (Pavlov, et al., 1997; 
1999), the “Wales-van Holde” ratio, ks/[η] (Wales and van Holde, 1954) and the 
persistence length, Lp (Kratky and Porod, 1949) have also been used to estimate dilute 
solution conformation (Table 2). 
 
This has resulted in chitosan being reported to have either a rigid rod-type structure 
(Terbojevich, et al., 1991; Errington, et al., 1993; Cölfen, et al., 2001; Fee, et al., 2003; 
Kasaai, 2006; Morris, et al., 2009a) or a semi-flexible-coil (Rinaudo, et al., 1993; Berth, 
et al., 1998; Brugnerotto, et al., 2001; Schatz, et al., 2003; Mazeau and Rinaudo, 2004; 
Vold, 2004; Lamarque, et al., 2005; Velásquez, et al., 2008).  It has also been shown that 
flexibility (in terms of persistence length) is moderately influenced by DA (Terbojevich, 
et al., 1991; Mazeau and Rinaudo, 2004).  
 
Chitosan complexation 
The ability of chitosan to complex with other ligands, metals for example, is well known 
(Rhazi, et al., 2002a,b).  The proclivity for chelation is dependent on physical state, -NH2 
content and distribution of chitosan, degree of polymerization, pH and cation content. It 
has been shown that following a higher degree of deacetylation, there is a characteristic 
increase in the degree of chelation.  The chelation takes place in chitosan with a degree of 
polymerization greater than 6 monomeric residues (Rhazi, et al., 2002b). In addition, the 
intensity of chitosan chelation is governed by nature of cation in solution. Studies have 
shown that the affinity of chitosan for divalent and trivalent cations of chloride salts 
shows selectivity in the following order: Cu2+ >> Hg2+ > Zn2+ > Cd2+ > Ni2+ > Co2+ 
Ca2+, Eur3+ > Nd3+ > Cr3+Pr3+ (Rhazi, et al., 2002b).  

Usage in Drug Delivery 
Chitosan is of great interest to the pharmaceutical industry in drug delivery and the 
number of publications on this subject has increased by almost an order of magnitude in 
the last decade (Figure 2).  Many aspects including biodegradation, biodistribution and 
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toxicity (Kean and Thanou, 2010); formulations for delivery of DNA and siRNA (Mao, et 
al., 2010); delivery systems for protein therapeutics (Amidi, et al., 2010); hydrogels for 
controlled, localized drug delivery (Bhattarai, et al., 2010); nanostructures for delivery of 
ocular therapeutics (de la Fuente, et al., 2010) and the targeted delivery of low molecular 
drugs (Park, et. al., 2010) have been reviewed in the most recent volume of Advanced 
Drug Delivery Reviews (Volume 62). 
 
The mucoadhesive properties of chitosan play an important role in its usage in oral, nasal 
and ocular drug delivery (Harding, et al., 1999; Illum, 2002; Harding, 2006).    
 
Mucoadhesion 
Mucoadhesion is the specific term for adhesion when one of the surfaces is mucus 
(Harding, et al., 1999). Mucus consists largely of water (> 95 %) and the high molecular 
weight glycoprotein mucin (Harding, et al., 1999; Harding, 2003; Harding, 2006).  The 
key sugar residues for mucoadhesive interaction are the acidic ones (N-acetyl neuraminic 
acid or “sialic acid”, and some sulphated galactose) and the hydrophobic methyl 
containing fucose.  Despite the polydispersity of these molecules compared to 
unglycosylated proteins, their structural hierarchy is also well understood.  They consist 
of M ~ 500 000 g/mol basic units linked linearly into “subunits” of M ~ 2 500 000 g/mol.  
These subunits are further linearly arrayed into macroscopic structures (M between 5 and 
50 000 000 g/mol) seen under the electron microscope (Harding, et al., 1983) or using 
atomic force microscopy (Deacon, et al., 2000).  Chitosan interacts strongly with the 
negatively sialic acid residues (Fiebrig, et al., 1994a,b; 1995a,b; Anderson, et al., 1989; 
Deacon, et al., 1999; Rossi, et al., 2000; 2001; Dodou, et al., 2005) although hydrogen 
bonding and hydrophobic interactions are also important (Deacon, et al., 1999; Qaqish 
and  Amiji, 1999; Dodou, et al., 2005; Sogias, et al., 2008).  The different theories 
explaining mucoadhesion and the properties of mucoadhesives are shown in Figure 3 
(Dodou, et al., 2005 and references therein).   The chitosan/ mucin interaction depends on 
the zeta potential of the mucin (Figure 4) (Takeuchi, et al. 2005) and this change in zeta 
potential is related to the concentration, molecular weight and charge of the chitosan 
(Figure 5) and to the pH (Takeuchi, et al. 2005; Sogias, et al., 2008). This change in zeta 
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potential is associated with a change particle size (Fiebrig, et al., 1994a,b; 1995a,b; 
Anderson, et al., 1989; Takeuchi, et al. 2005; Sogias, et al., 2008) (Table 3).   As a 
consequence the degree of chitosan/ mucin interaction is also dependent on the biological 
source of mucin (Figure 6). Drug delivery systems involving chitosan, therefore, show 
great potential and the use of encapsulation technology involving chitosan nano- or 
microparticles are increasing in populararity. 
 
Nanoparticles 
Chitosan has been widely used in the preparation of nanoparticles for drug delivery (Dyer 
et al., 2002; Fernández-Urrasuno, et al., 1999; Gan and Wang, 2007; Gan, et al., 2005; 
Luangtana-anan, et al., 2005; Shu and Zhu, 2000; Tsai, et al., 2008; Xu and Du 2005). 
Chitosan nanoparticles can be prepared by at least three different methods (Kumari, et. 
al., 2010): 
 
1. Electrostatic interaction and resultant ionotropic gelation between chitosan and 
the for example tripolyphosphate (TPP) polyanion (He, et al., 1998, 1999; Dyer, 
et al., 2002; Luangtana-anan, et al., 2005; Janes, et al., 2001; Shu and Zhu, 2000; 
Gan, et al., 2005; Morris, et al., 2010a) (Figure 7).   
2. Micro-emulsion for preparation of chitosan – glutaraldehyde complexes for 
example (Genta, et. al., 1998; Dhawan, et al., 2004).  
3. Polyelectrolyte complex (PEC) formation with for example pectin (MacLeod, et 
al., 1999; Ofori-Kwakye and Fell, 2001) or hyaluronic acid (Lim, et al., 2000; 
Kim, et al., 2004; Kujawa, et al., 2007).  This is of particular importance when a 
constant drug release profile is not desired (MacLeod, et al., 1999; Ofori-Kwakye 
and Fell, 2001). 
 
The size of the nanoparticles depends on the molecular weight of the chitosan polymer 
and higher molecular weight chitosans produce larger nanoparticles (Luangtana-anan et 
al., 2005; Morris, et al., 2010a). The method of cross-linking affects the mucoadhesive 
strength and stability of the nanoparticles (Genta, et. al., 1998; Dhawan, et al., 2004). 
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Stability 
The stability (shelf-life) of chitosan in terms of molar mass, viscosity and conformation is 
very important to pharmaceutical industry as these properties play an important role in 
the function of chitosan in formulations (Skaugrud, et al., 1999; Terbojevich and 
Muzzarelli, 2000). Chitosan storage conditions and particularly temperature may be 
important but whether or not chitosan depolymerisation will be detrimental to its intended 
application will depend on the functional significance of the changes that occur.  
Depolymerisation of chitosan in both the polymeric and nanoparticle form is temperature 
dependent (Nguyen, et al., 2007; Morris, et al., 2009b; Morris, et al., 2010a). For 
example it has been reported that low molar mass chitosans can cause more cell damage 
(Aspden, et al., 1996), although they may also prevent diabetes mellitus progression in 
mice to a greater extent than high molar chitosans (Kondo, et al., 2000), show greater 
antibacterial activity compared with high molar mass chitosans (Lui, et al., 2001) and 
whilst the high viscosities of high molar mass chitosans limit its biological usefulness, 
low molar mass chitosan is more soluble at neutral pH and therefore potentially more 
available in vivo (Harish Prashanth and Tharanathan, 2007).  However, it has also been 
reported that high molar mass chitosans show greater antibacterial activity compared with 
low molar mass chitosans (No, et al., 2006), that nasal insulin delivery (Aspden, et al., 
1997; Davis and Illum, 2000) is more effective with chitosan of molar mass greater than 
100000 g/mol and the reversibility of transepithelial chemical resistance (TEER) values 
decrease with decreased chitosan molar mass (Holme, et al., 2000). 
 
Pectin 
Chemical Structure 
Pectins are a complex family of heteropolysaccharides that constitute a large proportion 
of the primary cell walls of dicotyledons and play important roles in growth, development 
and senescence (van Buren, 1991; Tombs and Harding, 1998; Ridley, et. al., 2001; 
Willats, et. al., 2001).  Pectic polysaccharides are made of several structural elements the 
important of which are the homogalacturonan (HG) and type I rhamnogalacturonan (RG-
I) regions often described in simplified terms as the “smooth” and “hairy” regions 
respectively (Figure 8).  The HG region is composed of (1→4) linked α-D-GalpA 
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residues that can be partially methylated at C-6 (Pilnik and Voragen, 1970) and possibly 
partially acetyl-esterified at O-2 and/or O-3 (Rombouts and Thibault, 1986).  The degree 
of methylation (DM) and the degree of acetylation (DAc) are defined as the number of 
moles of methanol or acetic acid per 100 moles of GalA.  The degree of methylation in 
native pectins is generally in the order of DM  70-80; whereas degree of acetylation is 
generally much lower e.g. DAc  35 for sugar beet pectins (Rombouts and Thibault, 
1986).  Theoretically the degree of methoxyl esterification (DM) can range from 0-100 
%.  Pectins with a degree of esterification (DM) > 50% are known as high methoxyl 
(HM) pectins and consequently low methoxyl (LM) pectins have a DM < 50% (Walter, 
1991).  The RG-I region consists of disaccharide repeating unit [→4)-α-D-GalpA-(1→2)-
α-L-Rhap-(1→]n with a variety side chains consisting of L-arbinosyl and D-galactosyl 
residues (Voragen, et. al., 1995).  It has been reported that GalA residues in the RG-I 
region are partially acetylated (Ishii, 1997; Perrone, et. al., 2002) but not methylated 
(Komalavilas and Mort, 1989; Perrone, et. al., 2002).  In the case of sugar beet pectin the 
neutral side chain sugars are substituted with ferulic acid (Fry, 1982; Rombouts and 
Thibault, 1986) and there is evidence indicating that pectin chains can be dimerised via 
diferulic bridges (Levigne, et. al., 2004a,b).  There are a number of different ways in 
which ferulic acid can dimerise the most common being: 5-5’; 8-O-4’; 8-5’ cyclic and 8-
5’ non-cyclic dimers (Micard, et. al., 1997).   
 
Physical Properties 
The degree of esterification and therefore the charge on a pectin molecule is important to 
the functional properties in the plant cell wall.  It also significantly affects their 
commercial use as gelling and thickening agents (Lapasin and Pricl, 1995; Tombs and 
Harding, 1998).  HM pectins (low charge) form gels at low pH (< 4.0) and in the 
presence of a high amount (> 55 %) of soluble solids, usually sucrose (Oakenfull, 1991).  
HM pectin gels are stabilised by hydrogen-bonding and hydrophobic interactions of 
individually weak but cumulatively strong junction zones (Figure 9) (Oakenfull, 1991; 
Lopes da Silva and Gonçalves 1994; Pilnik, 1990; Morris, 1979).  Conversely, LM 
pectins (high charge) form electrostatically stabilised gel networks with/ or without sugar 
and with divalent metal cations, usually calcium in the so-called “egg-box” model 
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(Figure 10) (Morris, et. al., 1982; Pilnik, 1990; Morris, 1980; Oakenfull and Scott, 1998; 
Axelos and Thibault, 1991), which also depends on the distribution of negative 
carboxylate groups and structure breaking rhamnose side chains (Powell, et. al., 1982; 
Axelos and Thibault, 1991). A similar “egg-box” model has been proposed for alginate 
gels (Wang, et. al., 1994; Morris, 1980) from the results of circular dichroism (CD), 
small angle X-ray scattering (SAXS) and X-ray fibre diffraction respectively, it is thought 
that in both pectin and alginate the “egg-box” is formed in a two-step process – 
dimerisation followed by aggregation of the preformed “egg-boxes” (Thibault and 
Rinaudo, 1986). 
 
Solution properties such as viscosity also depend on degree of esterification, solvent 
environment (i.e. salt concentration, sugar concentration and pH) together with 
temperature (Oakenfull, 1991).  Hydrodynamic studies based on intrinsic viscosity ([η]), 
sedimentation coefficient (s020,w), radius of gyration (rg) and weight average molecular 
weight (Mw) have focussed on qualitative/ semi-quantitative methods of estimating the 
conformation based around “power law” Mark-Houwink-Kuhn-Sakurada relations 
(Tombs and Harding, 1998) which link intrinsic viscosity, sedimentation coefficient and 
radius of gyration with molar mass [η] ∝ Ma, s020,w ∝ Mb and rg ∝ Mc, where a, b and c 
have defined values for specific conformation types (Table 1). The translational frictional 
ratio, f/fo (Tanford, 1961), sedimentation conformation zoning (Pavlov, et al., 1997; 
1999), the “Wales-van Holde” ratio, ks/[η] (Wales and van Holde, 1954) and the 
persistence length, Lp (Kratky and Porod, 1949) have also been used to estimate dilute 
solution conformation (Table 2). A picture of a semi-flexible conformation for pectins 
irrespective of degree of esterification (and charge) has emerged from these studies 
(Anger and Berth, 1985; Axelos, et al., 1987; Axelos and Thibault, 1991, Berth, et al., 
1977; Harding, et al., 1991; Garnier, et al., 1993; Malovikova, et al., 1993; Cros, et al., 
1996; Tombs and Harding, 1998; Braccini, et al., 1999; Morris, et al., 2000, 2002, 2008; 
Fishman, et al., 2001, 2006; Noto, et al, 2005).  Pectin molecular weight and chain 
flexibility is important in mucoadhesive interactions (Nafee, et al., 2007).  
 
 10
Usage in Drug Delivery 
Pectins have been used is a gelling agent for a large number of years, however there has 
been recent interest in the use of pectin gels in controlled drug delivery (Sungthongjeen, 
et al., 2004; Lui, et al., 2003; Lui, et al., 2006).  This is in part due their long standing 
reputation of being non-toxic (GRAS – generally regarded as safe) (Lui, et al., 2003; Lui, 
et al., 2007; Watts and Smith, 2009), their relatively low production costs 
(Sungthongjeen, et al., 2004) and high availability (Beneke et al., 2009).  It is proposed 
that pectin could be used to deliver drugs orally, nasally and vaginally (Figure 11) 
(Peppas, et al., 2000; Sinha and Kumria, 2001; Lui, et al., 2003; Nafee, et al., 2004; 
Valenta, 2005; Lui, et al., 2007; Chelladurai, et al., 2008; Thirawong, et al., 2008), which 
are generally well accepted by patients (Lui, et al., 2003; Lui, et al., 2007; Yadav, et al., 
2009).   
 
Oral Delivery 
The oral route is of particular interest as in general oral drug administration results in less 
pain, greater convenience, higher compliance and reduced infection risk as compared to 
subcutaneous injections (Chen and Langer, 1998, Yadav, et al., 2009).  However, there 
are disadvantages associated with this route of administration such as low bioavailability 
due to relatively low passage of active agents across the mucosal epithelium, rapid 
polypeptide degradation due to action of digestive enzymes in the GI tract, enzymatic 
proteolysis and acidic degradation of orally administered drugs in the stomach (Lui, et 
al., 2003; Lin, et al., 2007). Various approaches have been made to increase the buccal 
penetration using permeation enhancers (Mesiha, et al., 1994; Carino, et al., 2000), 
protease inhibitors (Yamamoto, et al., 1994), enteric coatings (Morishita, et. al., 1993) 
and (bio)polymer micro-/ nano-sphere formulations (Sarmento, et al., 2007; Jain, et al., 
2005).  However, protein drugs are essentially free from enzymatic proteolysis and acidic 
degradation in the colon which has resulted in a concentrated effort to target their 
delivery to this organ (Sinha and Kumria, 2001; Lui, et al., 2003; Chambin, et al., 2006).  
Therefore a number of different polymers including pectin have been identified as 
protective agents against enzymatic proteolysis (Lui, et al., 2003; Sriamornsak, 2003; 
Pourjavadi and Barzegar, 2009).  The pectin-stabilised polypeptide drug therefore mains 
 11
intact in the stomach and small intestine prior to pectin digestion by the colonic 
microflora resulting in the release of drug molecule (Sinha and Kumria, 2001; 
Vandamme, et al., 2002).  The susceptibility of pectin to enzymatic attack is increased in 
the presence of calcium ions (Miler and MacMilan, 1970) and decreased by methyl 
esterification (Ashford, et al., 1993).  One problem with pectin formulations is that they 
can swell under physiological conditions which may result in premature drug release 
(Semdé, et al., 2000; Lui, et al., 2006), the effect can be minimised by the use of pectin in 
combination with other polymers: cellulosic or acrylic polymers (Semdé, et al., 2000); 
chitosan (Macleod, et al., 1999); hydroxypropylmethyl cellulose (Ofori-Kwakye and Fell, 
2001) and zein (Lui, et al., 2005; 2007). 
 
Nasal Delivery 
However, the clearance time through the whole alimentary tract is generally too short (4–
12 h), rendering oral drug administration a very inefficient process, with much of the 
drug unabsorbed. More recently interest has focused on drug absorption through nasal 
epithelia, which results in very rapid absorption ~ 15 minutes (Jabbal-Gill, et al., 1998). 
Other important issues are the degradation of peptide-based drugs in the gastrointestinal 
tract and low trans-mucosal permeability. Macromolecular based carrier and 
mucoadhesive systems have been considered for several years and pectin based systems 
have emerged as particularly promising.  Low methoxyl pectins are strongly polyanionic 
polyuronides from fruit used traditionally in jams and jellies (Rolin, 1993) and can also 
form weak gels in the presence of Ca2+ ions (8 meq/L), which occur naturally in nasal 
secretions (Chang and Su, 1989; Illum, 2000), and their texture makes them patient 
friendly in nasal delivery formulations (Dale, et al., 2002; Yadav, et al., 2009). These 
gels are pseudoplastic (Sriamornsak, 2004; Thirawong, et al., 2008; Chelladurai, et al., 
2008) and drug release is diffusion controlled at low pectin concentrations (Lui, et al., 
2007; Chelladurai, et al., 2008) and determined by gel dissolution at higher pectin 
concentration (Lui, et al., 2007) (Figure 12). In addition, this may hold an incorporated 
drug substance in the nasal cavity for a prolonged period and thereby modulate its rate of 
systemic absorption.  Pectins do not act as an absorption enhancer, however they cause 
tight junctions to open and therefore alter drug release characteristics due to the chelation 
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of calcium (Charlton, et al., 2007; McConaughy, et al., 2009). They are also highly 
mucoadhesive (Nafee, et al., 2004; Lui, et al., 2007; Thirawong, et al., 2008), although 
less mucoadhesive than chitosan (Nafee, et al., 2004).  Their mucoadhesive power 
depends on molecular weight, viscosity, the local pH and pectin functional groups (Lui, 
et al., 2007; Thirawong, et al., 2008). 
 
Nasal drug delivery is limited by the small sample volume that can be delivered ~ 150 µl, 
which is important in drug formulations especially if the drug is sparingly soluble or if a 
drug has to be delivered over prolonged period (Lui, et al., 2007). 
 
Vaginal Delivery 
Like the nose the vagina is another potential site for drug delivery due to its rich blood 
supply, large surface area (Vermani and Garg, 2000) and well understood microflora 
(Valenta, 2005).  Drug delivery release rates may vary during the menstrual cycle and 
this is especially important at the menopause (Valenta, 2005).  Drug delivery systems are 
based on mucoadhesion (Harding, et al., 1999; Harding, 2003; 2006). The vaginal route 
has been demonstrated to be favourable in the delivery of many drugs e.g. propranolol, 
human growth hormone, etc. (see Valenta, 2005 and references therein).  Furthermore it 
might be expected the vaginal delivery of hormonal contraception may be more efficient 
than the oral route (Valenta, 2005).  The vaginal route offers many of the advantages of 
the nasal route with main disadvantage being it is only available to females.  Pectin-based 
formulations have demonstrated highest mucoadhesive strength, highest swelling volume 
and lowest pH reduction in a trial (Balolu, et al., 2003; 2006). 
 
Stability 
However, as yet pectin has not fulfilled its potential as drug delivery system this is due 
variability in pectin formulations and question marks over formulation stability (Lui, et 
al., 2003; Lui, et al., 2006). According to Morris, et al. (2010b) the viscosity of pectin 
solutions decrease significantly after 6 months storage at 25 ºC and 40 ºC respectively, 
and this is reflected by a decrease in gel strength upon addition of calcium ions.  This is 
explained by a depolymerisation of pectin over time (Figure 13).  However, it has been 
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shown that decreases in viscosity of this magnitude do not significantly change the drug 
release rates from pectin gels in vitro (Nessa, 2003; Chelladurai, et al., 2008).  In calcium 
pectate based tablet formulations drug release time is increased with lower degree of 
methyl esterification, but higher levels of calcium ions can lead to disintegration of the 
tablet and increased drug release (Sungthongjeen, et al., 2004).  
 
Conclusions 
In the last decade there has been a great deal of interest in the use of polysaccharides and 
particularly chitosan and pectin in drug delivery systems. It is clear that both the 
polysaccharides either individually or together show great potential, however, many 
important issues still remain to be resolved fully. With chitosans, these include (i) their 
stability, with the important constraint that they are soluble only at pH < 6. (ii) their 
construction into microparticles capable of surviving the large environmental variation 
between mouth and intestine for oral drug delivery.  In addressing (i) and (ii) issues 
concerning the optimal degree of acetylation and molecular weight of the chitosan need 
to be addressed. With low methoxy-pectin systems issues include: (i) optimal molecular 
weight and degree of esterification (ii) drug diffusivity (iii) interactions with mucosal 
tissues, (iv) stability (molecular weight/viscosity/gelation). 
 
References 
 Amidi, M. and Hennink, W. E. (2010). Preface: Chitosan-based formulations of 
drugs, imaging agents and biotherapeutics. Advanced Drug Delivery Reviews, 62, 1–2. 
Amidi, M., Mastrobattista, E., Jiskoot, W. and Hennink, W. E. (2010). ChitosaN 
based delivery systems for protein therapeutics and antigens. Advanced Drug Delivery 
Reviews, 62, 59-82. 
 Anderson, M. T., Harding, S. E. and Davis, S. S. (1989). On the interaction in 
solution of a candidate mucoadhesive polymer, diethylaminoethyl-dextran, with pig 
gastric mucus glycoprotein. Biochemical Society Transactions, 17, 1101–1102.  
 Anger, H. and Berth, G. (1985). Gel-permeation chromatography of sunflower 
pectin. Carbohydrate Polymers, 5, 241-250. 
 14
Ashford, M., Fell, J. J., Attwood, D., Sharma, H. L. and Woodhead, P. J. (1993). 
An evaluation of pectin as a carrier for drug targeting to the colon. Journal of Controlled 
Release, 26, 213–220. 
Aspden, T. J., Illum, L. and Skaugrud, Ø. (1996). Chitosan as a nasal delivery 
system: evaluation of insulin absorption enhancement and effect on nasal membrane 
integrity using rat models. European Journal of Pharmaceutical Sciences, 4, 23-31. 
Aspden, T. J., Mason, J. D. T., Jones, N. S., Lowe, J., Skaugrud, Ø. and Illum, I. 
(1997).  Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro 
and in vivo mucociliary transport rates in human turbinates and volunteers. Journal of 
Pharmaceutical Sciences, 86, 509-513. 
Axelos, M. A. V. Lefebvre, J. and Thibault, J-F. (1987). Conformation of a low 
methoxyl citrus pectin in aqueous solution, Food Hydrocolloids, 1, 569-570.   
Axelos, M. A. V. and Thibault, J-F.  (1991).  The chemistry of low-methoxyl pectin 
gelation.  In: Walter R. H. (Ed.) The Chemistry and Technology of Pectin (pp 109-118).  
San Diego: Academic Press. 
 Balolu, E., Özyazici, M., Hizarciolu, S. Y. and Karavana. H. A. (2003). An in 
vitro investigation for vaginal bioadhesive formulations: bioadhesive properties and 
swelling states of polymer mixtures. Il Farmaco, 58, 391-396. 
 Balolu, E., Özyazici, M., Hizarciolu, S. Y., enyiit, T., Özyurt, D. and 
Pekçetin, C. (2006). Bioadhesive controlled release systems of ornidazole for vaginal 
delivery. Pharmaceutical Development and Technology, 11, 477-484. 
Beneke, C. M., Viljoen, A. M. and Hamman, J. H. (2009). Polymeric plant-derived 
excipients in drug delivery. Molecules, 14, 2602-2620. 
Berth, G., Anger, H. and Linow, F. (1977). Scattered-light photometric and 
viscosimetric studies of molecular mass determination of pectins in aqueous-solutions.  
Nahrung-Food, 31, 939-950.     
Berth, G., Dautzenberg, H. and Peter, M. G. (1998).  Physico-chemical 
characterization of chitosans varying in degree of acetylation. Carbohydrate Polymers, 
36, 205-216. 
 15
Bhattarai, N., Gunn, J. and Zhang, M. (2010). Chitosan-based hydrogels for 
controlled, localized drug delivery. Advanced Drug Delivery Reviews, 62, 83-99. 
Braccini, I., Grasso, R. P. and Perez, S.  (1999). Conformational and 
configurational features of acidic polysaccharides and their interactions with calcium 
ions: a molecular modeling investigation   Carbohydrate Research, 317, 199-130.  
Brugnerotto J., Desbrières J., Roberts G. and Rinaudo M. (2001). Characterization 
of chitosan by steric exclusion chromatography. Polymer, 42, 9921–9927. 
Chambin, O., Dupuis, G, Champion, D., Voilley, A. and Pourcelot, Y. (2006). 
Colon-specific drug delivery: Influence of solution reticulation properties upon pectin 
beads performance. International Journal of Pharmaceutics, 321, 86-93. 
Carino, G. P., Jacob, J. S. and Mathiowitz, E. (2000). Nanosphere based oral insulin 
delivery. Journal of Controlled Release, 65, 261–269. 
Charlton, S. T., Davis, S. S. and Illum, L. (2007). Evaluation of bioadhesive 
polymers as delivery systems for nose to brain delivery: In vitro characterisation studies. 
Journal of Controlled Release, 118, 225–234.  
Chelladurai, S., Mishra, M. and Mishra, B. (2008). Design and Evaluation of 
Bioadhesive in-Situ Nasal Gel of Ketorolac Tromethamine. Chemical and 
Pharmaceutical Bulletin, 56, 1596-1599. 
Chen, H. and Langer, L. (1998). Oral particulate delivery: status and future trends. 
Advanced Drug Delivery Reviews, 34, 339–350. 
Chien, Y. W., Su, K. S. E. and Chang, S. F. (1989). Nasal Systemic Drug Delivery 
(pp 1-26). New York: Marcel Dekker Inc. 
Cros, S. C., Garnier, C., Axelos, M. A. V., Imbery, A. and Perez, S.  (1996). 
Solution conformations of pectin polysaccharides: determination of chain characteristics 
by small angle neutron scattering, viscometry and molecular modeling.  Biopolymers, 39, 
339-352.  
Cölfen H., Berth, G. and Dautzenberg, H. (2001). Hydrodynamic studies on 
chitosans in aqueous solution.  Carbohydrate Polymers, 45, 373-383. 
 16
Dale, O., Hjortkjaer, R. and Kharasch, E. D. (2002). Nasal administration of 
opioids for pain management in adults. Acta Anaesthesiologica Scandinavica, 46, 759 –
770.  
Davis, S. S. (1989). Small intestine transit. In: Hardy, J. G., Davis, S. S. and 
Wilson, C. G. (Eds.) Drug Delivery to the Gastrointestinal Tract (pp. 49–61). Chichester: 
Ellis Horwood. 
Davis, S. S. and Illum, L. (2000).  Chitosan for oral delivery of drugs. In: 
Muzzarelli, R. A. A. (Ed.).  Chitosan per os: from Dietary Supplement to Drug Carrier 
(pp 137-164).  Grottammare: Atec. 
Deacon, M. P., Davis, S. S., White, R. J., Nordman, H., Carlstedt, I., N. Errington, 
N., Rowe, A. J. and Harding, S. E. (1999). Are chitosan–mucin interactions specific to 
different regions of the stomach? Velocity ultracentrifugation offers a clue. Carbohydrate 
Polymers, 38, 235–238. 
Deacon, M. P., McGurk, S., Roberts, C. J., Williams, P. M., Tendler, S. J. B., 
Davies, M. C., Davis, S. S. and Harding, S. E. (2000). Atomic force microscopy of 
gastric mucin and chitosan mucoadhesive systems, Biochemical Journal, 348, 557–563. 
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B. and Alonso, M. 
J. (2010). Chitosan-based nanostructures: A delivery platform for ocular therapeutics. 
Advanced Drug Delivery Reviews, 62, 100-117. 
Dhawan, S., Singla, A. K. and Sinha, V. R. (2004). Evaluation of mucoadhesive 
properties of chitosan microspheres prepared by different methods. AAPS PharmSciTech, 
5, 1-7. 
Dodou, D., Breedveld, P. and Wieringa, P. A. (2005). Mucoadhesives in the 
gastrointestinal tract: revisiting the literature for novel applications. European Journal of 
Pharmaceutics and Biopharmaceutics, 60, 1–16. 
Dyer, A. M., Hinchcliffe, M., Watts, P. Castile, J., Jabbal-Gill, Nankervis, I. R., 
Smith, A. and Illum, L. (2002). Nasal delivery of insulin using novel chitosan based 
formulations: a comparative study in two animal models between simple chitosan 
formulations and chitosan nanoparticles. Pharmaceutical Research, 19, 998-1008. 
 17
Errington, N., Harding, S. E., Vårum, K. M. and Illum, L. (1993). Hydrodynamic 
characterisation of chitosans varying in degree of acetylation.  International Journal of 
Biological Macromolecules, 15, 113-117. 
Fee, M., Errington, N., Jumel, K., Illum, L, Smith, A. and Harding, S. E. (2003). 
Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosans.  
European Biophysical Journal, 32, 457-464. 
Fernández-Urrasuno, R., Calvo, P., Rumuñán-Lopez, C., Vila-Jato, J. L. and 
Alonso, M. J. (1999). Enhancement of nasal absorption of insulin using chitosan 
nanoparticles. Pharmaceutical Research, 16, 1576-1581.  
Fishman, M. L., Chau, H. K., Hoagland, P. D., and Hotchkiss, A. T. (2006). 
Microwave-assisted extraction of lime pectin. Food Hydrocolloids, 20, 1170-1177. 
Fishman, M. L., Chau, H. K., Kolpak, F. and Brady, J.  (2001). Solvent effects on 
the molecular properties of pectins.  Journal of Agricultural and Food Chemistry, 49, 
4494-4501.  
Fiebrig, I., Davis, S. S. and Harding, S. E. (1995a). Methods used to develop 
mucoadhesive drug delivery systems: bioadhesion in the gastrointestinal tract. In: 
Harding, S. E., Hill, S. E. and Mitchell, J. R. (Eds.) Biopolymer mixtures (pp 373–419). 
Nottingham: Nottingham University Press. 
Fiebrig, I., Harding, S. E., & Davis, S. S. (1994a). Sedimentation analysis of the 
potential interactions between mucins and putative bioadhesive polymer. Progress in 
Colloid and Polymer Science, 93, 66–73. 
Fiebrig, I., Harding, S. E., Rowe, A. J., Hyman, S. C. and Davis, S. S. (1995b). 
Transmission electron microscopy studies on pig gastric mucin and its interactions with 
chitosan. Carbohydrate Polymers, 28, 239–244. 
Fiebrig, I., Harding, S. E., Stokke, B. T., Vårum, K. M., Jordan, D. and Davis, S. S. 
(1994b). The potential for chitosan as mucoadhesive drug carrier: studies on its 
interaction with pig gastric mucin on a molecular level. European Journal of 
Pharmaceutical Sciences, 2, 185. 
 18
Fry, S. C. (1982).  Phenolic compounds of the primary cell wall: feruloylated 
disaccharides of D-galactose and L-arabinose from spinach polysaccharide. Biochemical 
Journal, 203, 493-502. 
Gan, Q, and Wang, T. (2007).  Chitosan nanoparticle as protein delivery carrier 
Systematic examination of fabrication conditions for efficient loading and release. 
Colloids and Surfaces B: Biointerfaces, 59, 24–34. 
Gan, Q, Wang, T., Cochrane, C. and McCarron, P. (2005). Modulation of surface 
charge, particle size and morphological properties of chitosan–TPP nanoparticles 
intended for gene delivery. Colloids and Surfaces B: Biointerfaces, 44, 65–73. 
Garnier, C., Axelos M. A. V. and Thibault, J-F. (1993). Phase-diagrams of pectin-
calcium systems - influence of pH, ionic-strength, and temperature on the gelation of 
pectins with different degrees of methylation. Carbohydrate Research, 240, 219-232. 
Genta, I., Costantini, M., Asti, A., Conti, B. and Montanari, L. (1998). Influence of 
glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres. 
Carbohydrate Polymers, 36, 81-88. 
Harding, S. E. (2003). Mucoadhesive interactions. Biochemical Society 
Transactions, 31, 1036-1041. 
Harding, S. E. (2006). Trends in mucoadhesive analysis. Trends in Food Science 
and Technology, 17, 255-262. 
Harding, S. E., Berth, G., Ball, A., Mitchell, J. R. and Garcìa de la Torre, J.  (1991). 
The molecular weight distribution and conformation of citrus pectins in solution studied 
by hydrodynamics.  Carbohydrate Polymers, 16, 1-15. 
Harding, S. E., Davis, S. S., Deacon, M. P. and Fiebrig, I. (1999). Biopolymer 
mucoadhensives. In: Harding, S. E. (Ed.) Biotechnology and Genetic Engineering 
Reviews Vol. 16 (pp. 41-86).  Andover: Intercept. 
Harding, S. E., Rowe, A. J. and Creeth, J. M. (1983). Further evidence for a flexible 
and highly expanded spheroidal model for mucus glycoproteins in solution, Biochemical 
Journal, 209, 893-896. 
 19
Harish Prashanth, K. V. and Tharanathan R. N. (2007). Chitin/ chitosan: 
modifications and their unlimited potential – an overview. Trends in Food Science and 
Technology, 18, 117-131. 
He, P., Davis, S. S. and Illum, L. (1998). In-vitro evaluation of the properties of 
chitosan microspheres International Journal of Pharmaceutics, 166, 75–68.   
He, P., Davis, S.S., Illum, L. (1999). Chitosan microspheres prepared by novel 
modified spray drying methods. Journal of Microencapsulation, 16, 343-355.  
Holme, H. K., Davidsen, L., Kristiansen, A. and Smidsrød, O. (2008). Kinetics and 
mechanisms of the depolymerization of alginate and chitosan in aqueous solution. 
Carbohydrate Polymers, 73, 656-664. 
Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. 
Pharmaceutical Research, 15, 1326-1331.  
Illum, L. (2000). Improved delivery of drugs to mucosal services. European patent 
EP0975367B1. 
Illum L (2002) Nasal drug delivery: new. developments and strategies. Drug 
Discovery Today, 7, 1184–1189. 
Ishii, T. (1997).  O-acetylated oligosaccharides from pectins of potato tuber cell 
walls.  Plant Physiology, 113, 1265-1272.  
Jabbal-Gill, I., Fischer, A. N., Rappuoli, R., Davis, S. S. and Illum, L. (1998). 
Stimulation of mucosal and systemic responses against Bordetella pertussis filamentous 
haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan 
in mice. Vaccine, 16, 2039 –2046. 
Jain, D., Panda, A. K. and Majumdar, D. K. (2005). Eudragit S100 Entrapped 
Insulin Microspheres for Oral Delivery. AAPS PharmSciTech, 6, E100-E107. 
Janes, K. A., Calvo, P. and Alonso, M. J. (2001). Polysaccharide colloidal particles 
as delivery systems for macromolecules.  Advanced Drug Delivery Reviews, 47, 83–97. 
 20
Kasaai, M. R. (2006). Calculation of Mark–Houwink–Sakurada (MHS) equation 
viscometric constants for chitosan in any solvent–temperature system using experimental 
reported viscometric constants data. Carbohydrate Polymers, 68, 477-488. 
Kean, T. and Thanou, M. (2010). Biodegradation, biodistribution and toxicity of 
chitosan. Advanced Drug Delivery Reviews, 62, 3-11. 
Kim, S. J., Shin, S. R., Lee, K. B., Park, Y. D. and Kim, S. I. (2004). Synthesis and 
characteristics of polyelectrolyte complexes composed of chitosan and hyaluronic acid. 
Journal of Applied Polymer Science, 91, 2908–2913. 
Komalavilas, P. and Mort, A. J. (1989).  The acetylation of O-3 of galacturonic acid 
in the rhamnose-rich portion of pectin. Carbohydrate Research, 189, 261-272. 
Kondo, Y., Nakatani, A., Hayashi, K. and Ito, M. (2000). Low molecular weight 
chitosan prevents the progression of low dose streptozotocin induced slowly progressive 
diabetes mellitus in mice. Biological and Pharmacological Bulletin, 23, 1458-1464. 
Kratky, O. and Porod, G.  (1949). Röntgenungtersuchung gelöster fadenmoleküle.  
Recueil Des Travaux Chimiques Des Pays-Bas, 68, 1106-1109.  
Kubota, N. and Eguchi, Y. (1997). Facile preparation of water-soluble n-acetylated 
chitosan and molecular weight dependence of its water-solubility. Polymer Journal, 29, 
123-127. 
Kumari, A., Yadav, S. K. and Yadav, S. C. (2010). Biodegradable polymeric 
nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75, 1-
18. 
Kujawa, P., Schmauch, G., Viitala, T., Badia, A. and Winnik, F. M. (2007). 
Construction of viscoelastic biocompatible films via the layer-by-layer assembly of 
hyaluronan and phosphorylcholine-modified chitosan. Biomacromolecules, 8, 3169-3176. 
Lamarque, G., Lucas, J-M., Viton, C. and Domard, A. (2005). Physicochemical 
behavior of homogeneous series of acetylated chitosans in aqueous solution: role of 
various structural parameters.  Biomacromolecules, 6, 131-142. 
 21
Lapasin, R. and Pricl. S. (1995).  Rheology of Industrial Polysaccharides, Theory 
and Applications.  Blackie, London, UK. 
 LeHoux, J-G. and Depuis, G. (2007).  Recovery of chitosan from aqueous acidic 
solutions by salting-out: Part 1. Use of inorganic salts. Carbohydrate Polymers, 68, 295-
304. 
Levigne, S., Ralet, M-C., Quéméner, B. and Thibault, J-F. (2004a).  Isolation of 
diferulic bridges ester-linked to arabinan in sugar beet cell walls.  Carbohydrate 
Research, 339, 2315-2319.  
Levigne, S., Ralet, M-C., Quéméner, B. C., Pollet, B. N-L., Lapierre, C. and 
Thibault, J-F. (2004b). Isolation from sugar beet cell walls of arabinan oligosaccharides 
esterified by two ferulic acid monomers.  Plant Physiology, 134, 1173-1180.  
Lim, S. T., Martin, G. P., Berry, D. J. and Brown, M. B. (2007). Preparation and 
evaluation of the in vitro drug release properties and mucoadhesion of novel 
microspheres of hyaluronic acid and chitosan. Journal of Controlled Release, 66, 281–
292. 
Lin, Y. H., Chen, C. H., Liang, H. F., Kulkarni, A. R., Lee, P. W., Chen, C. H. and 
Sung, H. W. (2007). Novel nanoparticles for oral insulin delivery via the paracellular 
pathway. Nanotechnology, 18, 1-11. 
Lopes da Silva, J. A. and Gonçalves, M. P. (1994).  Rheological study into the 
ageing process of high methoxyl pectin/ sucrose gels.  Carbohydrate Polymers, 24, 235-
245.  
Luangtana-anan, M., Opanasopit, P., Ngawhirunpat, T., Nunthanid, J., 
Sriamornsak, P., Limmatvapirat, S. and Lim, L. Y. (2005). Effect of chitosan salts and 
molecular weight on a nanoparticulate carrier for therapeutic protein. Pharmaceutical 
Development and Technology, 10, 189–196. 
Lui, L., Fishman, M. L. and Hicks, K. B. (2007). Pectin in controlled drug delivery 
– a review.  Cellulose, 14, 15-24. 
Lui, L., Fishman, M. L., Hicks, K. B. and Kende, M. (2005). Interaction of various 
pectin formulations with porcine colonic tissues.  Biomaterials, 26, 5907–5916. 
 22
Lui, L., Fishman, M. L., Kost, J. and Hicks, K. B. (2003). Pectin-based systems for 
colon-specific drug delivery via oral route.  Biomaterials, 24, 3333-3343. 
Liu, X. F., Guan, Y. L., Yang, D. Z., Li, Z. and De Yao, K. (2001). Antibacterial 
action of chitosan and carboxymethylated chitosan. Journal of Applied Polymer Science, 
79, 1324-1335.  
Macleod, G. S., Collett, J. H. and Fell, J. T. (1999). The potential use of mixed 
films of pectin, chitosan and HPMC for bimodal drug release. Journal of Controlled 
Release, 58, 303–310.  
Malovikova, A., Rinaudo, M. and Milas, M. (1993). On the characterization of 
polygalacturonate salts in dilute-solution. Carbohydrate Polymers, 22, 87-92.  
Mao, S., Sun, W. and Kissel, T. (2010). Chitosan-based formulations for delivery of 
DNA and siRNA. Advanced Drug Delivery Reviews, 62, 12-27. 
Mazeau K. and Rinaudo M. (2004). The prediction of the characteristics of some 
polysaccharides from molecular modelling. Comparison with effective behaviour. Food 
Hydrocolloids, 18, 885–898. 
McConaughy, S. D., Kirkland, S. E., Treat, N. J. Stroud, P. A. and McCormick, C. 
L. (2009). Tailoring the network properties of ca2+ crosslinked aloe vera polysaccharide 
hydrogels for in situ release of therapeutic agents. Biomacromolecules, 9, 3277-3287. 
Mesiha, M., Plakogiannis, F. and Vejosoth, S. (1994). Enhanced oral absorption of 
insulin from desolvated fatty acid-sodium glycocholate emulsions. International Journal 
of Pharmaceutics, 111, 213–216. 
Micard, V., Grabber, J. H., Ralph, J., Renard, C. M. C. G. and Thibault, J-F. (1997).  
Dehydrodiferulic acids from sugar beet pulp.  Phytochemistry, 44, 1365-1368. 
Miller, L. and MacMilan, J. D. (1970). Mode of action of pectic enzymes. 2. 
Further purification of exopolygalacturonate lyase and pectinesterases from Clostridium 
multifermerans. Journal of Bacteriology, 102, 72–78.  
 23
Morishita, I., Morishita, M., Takayama, K., Machida, Y. and Nagai, T. (1993). 
Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 
and S100. International Journal of Pharmaceutics, 91, 29-37. 
Morris, E. R. (1980).  Physical probes of polysaccharide conformation and 
interactions.  Food Chemistry, 6, 15-39. 
Morris, E. R., Powell, D. A., Gidley, M. J. and Rees, D. A. (1982.)  Conformation 
and interactions of pectins I.  Polymorphism between gel and solid states of calcium 
polygalacturonate.  Journal of Molecular Biology, 155, 507-516.  
Morris, G. A., Foster, T. J. and Harding, S. E. (2000). The effect of degree of 
esterification on the hydrodynamic properties of citrus pectin. Food Hydrocolloids, 14, 
227-235. 
Morris, G. A., Foster, T. J. and Harding, S. E. (2002).  A hydrodynamic study of 
the depolymerisation of a high methoxy pectin at elevated temperatures.  Carbohydrate 
Polymers, 48, 361-367. 
Morris, G. A., García De La Torre, J., Ortega, A., Castile, J., Smith, A., and 
Harding, S. E. (2008). Molecular flexibility of citrus pectins by combined sedimentation 
and viscosity analysis. Food Hydrocolloids, 22, 1435-1442. 
Morris, G. A., Castile, J., Smith, A., Adams, G. G., and Harding, S. E. (2009a). 
Macromolecular conformation of chitosan in dilute solution: a new global hydrodynamic 
approach. Carbohydrate Polymers, 76, 616-621.  
Morris, G. A., Castile, J., Smith, A., Adams, G. G., and Harding, S. E. (2009b). The 
kinetics of chitosan depolymerisation at different temperatures. Polymer Degradation 
and Stability, 94, 1344-1348, 2009.  
Morris, G. A., Castile, J., Smith, A., Adams, G. G., and Harding, S. E. (2010a).  
The effect of different storage temperatures on the stability of tripolyphosphate (TPP) – 
chitosan nanoparticles (submitted). 
Morris, G. A., Castile, J., Smith, A., Adams, G. G. and Harding, S. E. (2010b). The 
effect of different storage temperatures on the physical properties of pectin solutions and 
gels (submitted). 
 24
Muzzarelli, R. A. A. (2009). Genipin-crosslinked chitosan hydrogels as biomedical 
and pharmaceutical aids.  Carbohydrate Polymers, 77, 1-9. 
Nafee, N. A., Ismail, F. A., Boraie, N. A. and Mortada, L. M. (2004). 
Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal 
tablet formulation. Drug Development and Industrial Pharmacy, 30, 985-993. 
Nessa, M. U. (2003). Physiochemical characterisation of pectin solution as a 
vehicle for nasal drug delivery.  MSc Dissertation, University of Nottingham, U.K. 
Nguyen, T. T. B., Hein, S., Ng, C-H. and Stevens, W. F. (2007). Molecular stability 
of chitosan in acid solutions stored at various conditions. Journal of Applied Polymer 
Science, 107, 2588–2593. 
No, H. K., Kim, S. H., Lee, S. H., Park, N. Y. and Prinyawiwatkul, W. (2006). 
Stability and antibacterial activity of chitosan solutions affected by storage temperature 
and time. Carbohydrate Polymers, 65, 174-178. 
Noto, R., Martorana, V., Bulone, D. and San Biagio, B. L.  (2005). Role of charges 
and solvent on the conformational properties of poly(galacturonic acid) chains: a 
molecular dynamics study.  Biomacromolecules, 6, 2555-2562.   
Oakenfull, D. G. (1991). The Chemistry of High-Methoxyl Pectins.  In: Walter RH 
(Ed.) The Chemistry and Technology of Pectin, pp 87-108.  Academic Press, San Diego. 
Oakenfull, D. G. and Scott, A. (1998).  Milk gels with low methoxy pectins. In: 
Phillips, G. O., Williams, P. A. and Wedlock, D. J. (Eds.)  Gums and Stabilisers for the 
Food Industry 9 (pp 212-221).  Oxford: Oxford University Press. 
Ofori-Kwakye, K. and Fell, J. T. (2001).  Biphasic drug release: the permeability of 
films containing pectin, chitosan and HPMC. International Journal of Pharmaceutics, 
226, 139–145.  
Ogawa, K. and Yui, T. (1994). Effect of explosion on the crystalline polymorphism 
of chitin and chitosan. Bioscience Biotechnology and Biochemistry, 58. 968-969.  
 25
Park, J. H., Saravanakumar, G., Kim, K. and Kwon, I. C. (2010). Targeted delivery 
of low molecular drugs using chitosan and its derivatives. Advanced Drug Delivery 
Reviews, 62, 28-41. 
Park, J. W., Choi, K-H. and Park, K. K. (1983). Acid-base equilibria and related 
properties of chitosan. Bulletin of the Korean Chemical Society, 4, 68-72.  
Pavlov, G. M., Rowe, A. J. and Harding, S. E.  (1997). Conformation zoning of 
large molecules using the analytical ultracentrifuge.  Trends in Analytical Chemistry, 16, 
401-405. 
Pavlov, G. M. Harding, S. E. and Rowe, A. J.  (1999). Normalized scaling relations 
as a natural classification of linear macromolecules according to size.  Progress in 
Colloid and Polymer Science, 113, 76-80. 
Peppas, N. A., Bures, P., Leobandung, W. and Ichikawa, H. (2000). Hydrogels in 
pharmaceutical formulations. European Journal of Pharmaceutics and 
Biopharmaceutics, 50, 27-46. 
Perez, S., Rodríguez-Carvajal, M. A. and Doco, T.  (2003). A complex plant cell 
wall polysaccharide: rhamnogalacturonan II. A structure in quest of a function.  
Biochimie, 85, 109-121.    
Perrone, P., Hewage, H. C., Thomson, H. R., Bailey, K., Sadler, I. H. and Fry, S. C. 
(2002).  Patterns of methyl and O-acetyl esterification in spinach pectins: a new 
complexity.  Phytochemistry, 60, 67-77. 
Pilnik, W, (1990).  Pectin - a many splendored thing. In: Phillips, G. O., Williams, 
P. A. and Wedlock,  D. J. (Eds.)  Gums and Stabilisers for the Food Industry 5 (pp. 209-
222).  Oxford: IRL Press. 
Pilnik, W. and Voragen A. G. J. (1970).  Pectin substances and their uronides.  In: 
Hulme, A. C. (Ed.) The Biochemistry of Fruits and their Products (pp 53-87). New York: 
Academic Press. 
Pourjavadi A. and Barzegar, S. (2009).  Smart pectin-based superabsorbent 
hydrogel as a matrix for ibuprofen as an oral non-steroidal anti-inflammatory drug 
delivery. Starch/ Stärke, 61, 173-187. 
 26
Powell, D. A., Morris, E. R., Gidley, M. J. and Rees, D. A. (1982).  Conformation 
and interactions of pectins II.  Influence of residue sequence on chain association in 
calcium pectate gels.  Journal of Molecular Biology, 155, 317-331. 
Qaqish, R. B. and Amiji, M. M. (1999). Synthesis of a fluorescent chitosan 
derivative and its application for the study of chitosan-mucin interactions.  Carbohydrate 
Polymers, 38, 99-107. 
Rhazi, M., Desbriéres J., Tolaimate, A., Rinaudo, M., Vottero, P. and Alagui, A. 
(2002a). Contribution to the study of the complexation of copper by chitosan and 
oligomers. Polymer, 43, 1267–76.  
Rhazi, M., Desbriéres J., Tolaimate, A., Rinaudo, M., Vottero, P., Alagui, A. and El 
Meray, M. (2002b). Influence of the nature of the metal ions on the complexation with 
chitosan.: Application to the treatment of liquid waste. European Polymer Journal, 38, 
1523-1530.  
Ridley, B. L., O’Neil, M. A. and Mohnen, D. (2001).  Pectins: structure, 
biosynthesis and oligogalacturonide-related signalling.  Phytochemistry, 57, 929-967. 
Rinaudo, M. (2006). Chitin and chitosan: properties and applications. Progress in 
Polymer Science, 31, 603-632. 
Rolin, R. (1993). Pectin. In: Whistler, R. L. and BeMiller, J. N. (Eds.) Industrial 
Gums (pp 257-293). New York: Academic Press. 
Rombouts, F. M. and Thibault, J-F. (1986).  Sugar beet pectins: chemical structure 
and gelation through oxidative coupling.  In: Fishman, M. L. and Jen, J. J. (Eds.) The 
Chemistry and Function of Pectins (pp 49-60). Washington DC: American Chemical 
Society.  
Rossi, S., Ferrari, F., Bonferoni, M. C. and Caramella, C. (2000). Characterization 
of chitosan hydrochloride–mucin interaction by means of viscosimetric and turbidimetric 
measurements. European Journal of Pharmaceutical Sciences, 10, 251–257. 
 27
Rossi, S., Ferrari, F., Bonferoni, M. C. and Caramella, C. (2001). Characterization 
of chitosan hydrochloride–mucin rheological interaction: influence of polymer 
concentration and polymer: mucin weight ratio. European Journal of Pharmaceutical 
Sciences, 12, 479–485. 
Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D. and Neufeld, R. (2007). Oral 
bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules, 
8, 3054-3060 
Schatz, S. Viton, C., Delair, T. Pichot, C. and Domard, A. (2003). Typical 
physicochemical behaviors of chitosan in aqueous solution.  Biomacromolecules, 4, 641-
648. 
Semdé, R., Amighi, K., Devleeschouwer, M. J. and Moës, A. J. (2000). Studies of 
pectin HM/Eudragit® RL/Eudragit® NE film-coating formulations intended for colonic 
drug delivery. International Journal of Pharmaceutics, 197, 181–192.  
Shu, X. Z., and Zhu, K. J. (2000). A novel approach to prepare tripolyphosphate: 
chitosan complex beads for controlled release drug delivery. International Journal of 
Pharmaceutics, 201, 51–58. 
Sinha, V. R. and Kumria, R. (2001). Polysaccharides in colon-specific drug 
delivery. International Journal of Pharmaceutics, 224, 19–38. 
Skaugrud, Ø., Hagen, A., Borgersen, B. and Dornish, M. (1999). Biomedical and 
pharmaceutical applications of alginate and chitosan. In: Harding, S. E. (Ed.) 
Biotechnology and Genetic Engineering Reviews Vol. 16 (pp 23-40).  Andover: Intercept. 
Sogias, I. A., Williams, A. C. and Khutoryanskiy, V. V. (2008). Why is chitosan 
mucoadhesive? Biomacromolecules, 9, 1837–1842. 
Sriamornsak, P. (2003). Chemistry of pectin and its pharmaceutical uses: a review. 
Silpakorn University International Journal, 3, 206–228. 
Sungthongjeen, S., Sriamornsak, P., Pitaksuteepong, T., Somsiri, A. and 
Puttipipatkhachorn, S. (2004). Effect of degree of esterification of pectin and calcium 
amount on drug release from pectin-based matrix tablets.  AAPS PharmSciTech, 5, 1-9. 
 28
Takeuchi, H., Thongborisute, J., Matsui, Y., Sugihara, H., Yamamoto, H. and 
Kawashima, Y. (2005). Novel mucoadhesion tests for polymers and polymer-coated 
particles to design optimal mucoadhesive drug delivery systems. Advanced Drug 
Delivery Reviews, 57, 1583– 1594. 
Tanford, C. (1961). Physical Chemistry of Macromolecules. New York: John Wiley 
& Sons. 
Terbojevich, M. Cosani, A., Conio, G., Marsano, E. and Bianchi, E.  (1991). 
Chitosan: chain rigidity and mesophase formation.  Carbohydrate Research, 209, 251-
260. 
Terbojevich, M. and Muzzarelli, R. A. A. (2000). Chitosan. In: Phillips, G. O. and 
Williams, P. A. (Eds.).  Handbook of Hydrocolloids (pp 367-378). Cambridge: 
Woodhead Publishing Ltd.  
Thibault, J-F. and Rinaudo, M. (1986).  Chain association of pectic molecules 
during calcium-induced gelation.  Biopolymers, 25, 455-468. 
Thirawong, N., Kennedy, R. A. and Sriamornsak, P. (2008). Viscometric study of 
pectin–mucin interaction and its mucoadhesive bond strength. Carbohydrate Polymers, 
71, 170-179.  
Tombs M. P., and Harding, S. E.  (1998). An Introduction to Polysaccharide 
Biotechnology. London: Taylor and Francis.   
Tsai, M. L., Bai, S. W., and Chen, R. H. (2008). Cavitation effects versus stretch 
effects resulted in different size and polydispersity of ionotropic gelation chitosan–
sodium tripolyphosphate nanoparticle.  Carbohydrate Polymers, 71, 448-457. 
Valenta, C. (2005). The use of mucoadhesive polymers in vaginal delivery. 
Advanced Drug Delivery Reviews, 57, 1692– 1712. 
van Buren, J. P. (1991).  Function of pectin in plant tissue structure and firmness.  
In: Walter, R. H. (Ed).  The Chemistry and Technology of Pectin (pp 1-22).  San Diego: 
Academic Press. 
 29
Vandamme, T. F., Lenourry, A., Charrueau, C. and Chaumeil, J-C. (2002). The use 
of polysaccharides to target drugs to the colon. Carbohydrate Polymers, 48, 219-231. 
Vårum, K. M., Anthonsen, M. W., Grasdalen, H. and Smidsrød, O. (1991a). 
Determination of the degree of N-acetylation and distribution of N-acetyl groups in 
partially N-deacteylated chitins (chitosans) by high-field NMR spectroscopy.  
Carbohydrate Research, 211, 17-23. 
Vårum, K. M., Anthonsen, M. W., Grasdalen, H. and Smidsrød, O. (1991b). 13C 
NMR studies of the acetylation sequences in partially N-deacteylated chitins (chitosans).  
Carbohydrate Research, 217, 19-27. 
Vårum, K. M., Ottøy, M. H. and Smidsrød, O. (1994). Water-solubility of partially 
N-acetylated chitosans as a function of pH: effect of chemical composition and 
depolymerisation. Carbohydrate Polymers, 25, 65-70. 
Velásquez, C. L., Albornoz, J. S. and Barrios, E. M. (2008). Viscosimetric studies 
of chitosan nitrate and chitosan chlorhydrate in acid free NaCl aqueous solution. E-
Polymers, 014. 
Vermani, K. and Garg, S. (2000). The scope and potential of vaginal drug delivery, 
Pharmaceutical Science & Technology Today, 3, 359– 364. 
Vold, I. M. N. (2004). Periodate Oxidised Chitosans: Structure and Solution 
Properties.  PhD Dissertation, Norwegian University of Science and Technology, 
Trondheim, Norway.  
Voragen, A. G. J., Pilnik, W., Thibault, J-F., Axelos, M. A. V. and Renard, C. M. 
G. C. (1995).  Pectins. In: Stephen, A. M. (Ed.) Food polysaccharides and their 
interactions (pp 287-340). New York: Marcel Dekker.  
Wales, M. and van Holde, K. E.  (1954). The concentration dependence of the 
sedimentation constants of flexible macromolecules.  Journal of Polymer Science, 14, 81-
86. 
Wang, Z-Y., White, J. W., Konno, M., Saito, S. and Nozawa, T. (1994).  A small-
angle X-ray scattering study of alginate solution and its sol-gel transition by addition of 
divalent cations.  Biopolymers, 35, 227-238. 
 30
Watts, P. and Smith, A. (2009). PecSys: in situ gelling system for optimised nasal 
drug delivery. Expert Opinion on Drug Delivery, 6, 543-552.     
Willats, W. G. T., McCartney, L., Mackie, W. and Knox J. P. (2001).  Pectin: cell 
biology and prospects for functional analysis.  Plant Molecular Biology, 47, 9-27. 
Xu, Y. and Du, Y. (2005). Effect of molecular structure of chitosan on protein 
delivery properties of chitosan nanoparticles. International Journal of Pharmaceutics, 
250, 215-226. 
Yadav, N., Morris, G. A., Harding, S. E., Ang, S. and Adams, G. G. (2009). 
Various non-injectable delivery systems for the treatment of diabetes mellitus. Endocrine, 
Metabolic & Immune Disorders - Drug Targets, 9, 1-13. 
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M. and 
Muranishi, S. (1994). Effects of various protease inhibitors on the intestinal absorption 
and degradation of insulin in rats. Pharmaceutical Research, 11, 1496–1500. 
Yen, M-T. and Mau, J-L. (2007). Physico-chemical characterization of fungal 
chitosan from shiitake stipes. LWT - Food Science and Technology, 40, 472-479. 
 
 31
Table 1. The Mark-Houwink-Kuhn-Sakurada (MHKS) power law exponents (a, b and c), 
and the Wales – van Holde (ks/[η]) for the conformations described by sedimentation 
conformation zoning. 
 
Zone A 
Extra-rigid rod 
Zone B 
Rigid rod 
Zone C 
Semi-flexible coil 
Zone D 
Random coil 
Zone E 
Spherical 
a > 1.4 0.8 – 1.4 0.5 – 0.8 0.2 – 0.5 0.0 
b < 0.2 0.2 – 0.4 0.4 – 0.5 0.5 – 0.6 0.67 
c > 0.8 0.6 – 0.8 0.5 – 0.6 0.4 – 0.5 0.33 
ks/[η] < 0.2 0.2 – 0.4 0.4 – 1.0 1.0 - 1.4 1.6 
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Table 2. Estimations of the dilute solution conformation of pectin  
a 0.62 – 0.94 0.77 – 1.1 
b 0.17 0.24 – 0.25 
c 0.57 0.55 – 0.56 
ks/[η] 0.10 – 0.85 0.16 – 0.73 
f/f0 7 – 10 11 - 16 
Lp (nm) 10 - 15 4 - 35 
Zone A/B/C B/C 
References 
Anger and Berth, 1985; Axelos, et 
al., 1987; Axelos and Thibault, 
1991, Berth, et al., 1977; Harding, 
et al., 1991; Garnier, et al., 1993; 
Malovikova, et al., 1993; Tombs 
and Harding, 1998; Morris, et al., 
2000, 2002, 2008; Fishman, et al., 
2001, 2006 
Terbojevich, et al., 1991; Errington, 
et al., 1993; Ottøy, et al., 1996; Berth, 
et al., 1998; Cölfen, et al, 2001; 
Brugnerotto, et al., 2001; Fee, et al., 
2003; Schatz, et al., 2003; Mazeau 
and Rinaudo, 2004;  Vold, 2004; 
Lamarque, et al., 2005; Rinaudo, 
2006; Kasaai, 2006; Velásquez, et al., 
2008; Morris, et al., 2009 
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Table 3. Mucoadhesive analysis. The sedimentation coefficient ratio (scomplex/smucin) as an 
index of (muco)adhesiveness (from Fiebrig, et al., 1994a,b; 1995a,b; Anderson, et al., 
1989) (adapted from Table 1 in Harding (2003)). 
Mucoadhesive scomplex/smucin Conditions 
DEAE-dextran 1.1–1.9a pH 6.8, 20 ºC 
 
1.2–1.4a pH 6.8, 37 ºC 
Chitosan (FA ≈ 0.11) 48 pH 6.5, 20 ºC 
 
15 pH 4.5, 20 ºC 
 
22 pH 2.0, 20 ºC 
 
12 pH 2.0, 37 ºC 
 
26 pH 4.5, 20 ºC + 3 mM bile salt 
 
35 pH 4.5, 37 ºC + 3 mM bile salt 
 
18 pH 4.5, 20 ºC + 6 mM bile salt 
 
14 pH 4.5, 37 ºC + 6 mM bile salt 
Chitosan (FA ≈ 0.42) 31 pH 4.5, 20 ºC 
 
44 pH 4.5, 37 ºC 
aDepends on the mixing ratio 
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
Figure 1. Schematic representation of the structure repeat units of chitosan, where R = 
Ac or H depending on the degree of acetylation. 
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Figure 2. Number of publications on chitosan in drug delivery over the last 10 years 
(adapted from Figure 1 in Amidi and Hennink (2010)). 
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Figure 3. Theories of mucoadhesion (red circles) and material properties of 
mucoadhesives (blue circles). The overlapping areas between the circles of the material 
properties and the mucoadhesive theories indicate how and to what extent the former are 
connected to the latter (adapted from Figure 2 in Dodou, et al. (2005)). 
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                 (e) 
 
 
 
 
 
 
 
Figure 6. Zeta potential of coarse mucin particles in the solutions of chitosan having 
different molecular weight with various concentrations and different pH. (a) pH 5.0, (b) 
pH 6.8, (c) pH 7.4, (d) pH 9.0, (e) Change in observed particle size of micronized mucin 
particles when mixed with the chitosan solutions. Concentration of chitosan solution: 
1.5% w/v. pH of solution: 6.8. Molecular weight of chitosan: CS-2 = 20000; CS-5 = 
50000 and CS-15 = 150000 g/mol respectively (adapted from Figures 1 and 3 in 
Takeuchi, et al. (2005)). 
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Figure 5. Dynamic light scattering size measurements of pig gastric mucin mixed with 
chitosan at pH 2.0 (1), half acetylated chitosan at pH 7.0 (2), and half acetylated chitosan 
at pH 2.0 (3) at [polymer]/[mucin] weight ratio = 0.05. Insets: pig gastric mucin at pH 2.0 
before (a) and after (b) addition of chitosan (adapted from Figure 3 in Sogias, et al. 
(2008)). 
 
 39
 
Figure 6. Comparison of the interaction between ‘‘SC210+’’ chitosan with three mucin 
populations purified from different regions of the porcine stomach (cardia, corpus-LD 
and antrum-LD) and one mucin population purified from the whole porcine stomach 
(PGM-MD). (a) I = 0.1 M, (b) I = 0.2 M (adapted from Figure 2 in Deacon, et al. 
(1999)). 
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Figure 7. Transmission electron microscopy image of a chitosan–TPP nanoparticle of 
diameter 140 – 250 nm (adapted from Figure 10 in Gan, et al. (2003)). Inset: particle size 
distribution measured by differential sedimentation for TPP-chitosan nanoparticles with a 
mean particle size of 141 nm (adapted from Figure 3 in Morris, et al. (2010a)).  
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Figure 8. Schematic structure for pectin: galacturonic acid (); galactose (); arabinose 
(); rhamnose () and methyl groups () (adapted from Figure 1 in Perez, et al. (2003)). 
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Figure 9. Representation of gelation mechanism in high methoxyl (HM) pectin gels, 
where the junction zones are indicated in red.   
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Figure 10. “Egg box” model for the gelation mechanism for low methoxyl (LM) pectin 
gels. 
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Figure 11.  Major sites for pectin drug delivery systems (adapted from Peppas, et al., 
2000; Harding, 2003; Lui, et al., 2003; Valenta, 2005) with insets showing the nasal 
cavity, vagina and GI tract. 
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Figure 12. Mass uptake by nasal cavity tissues from pectin derivative carrying a primary 
amine gel formulation: Pectin (solid bar), BSA (open bar). Study was performed under 
standard tissue culture conditions (CO2 5%, O2 95%) at 37 ºC for 4 h. The amounts of 
adsorbed pectin and BSA were determined according to Liu, et al. (2005). Nasal cavity 
tissues were harvested from a freshly slaughtered healthy adult swine from a local 
slaughterhouse (adapted from Figure 4B in Lui, et al. (2007)). 
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Figure 13. 1st order kinetic plots of (mol/g) vs. time (days) for pectin of DM ~ 19 %, 
where closed symbols represent molar masses estimated from viscometry at 4 °C (!), 25 
°C (,) and 40 °C (7) (adapted from Figure 3 in Morris, et al. (2010b)).  The kinetic rate 
constants (day-1) are (-0.8 ± 1.1) x 10-7, (5.7 ± 1.1) x 10-7 and (6.7 ± 0.2) x 10-6 at 4 ºC, 25 
ºC and 40 ºC, respectively. 
 
